🤖 Search 5,000+ AI tools Ask our bot for help →

Discover the latest tools and trends in AI 🔮

Join 50,000+ subscribers including Amazon, Apple, Google, and Microsoft employees reading our free newsletter.

[email protected] Subscribe

Cognivia bags €15.5M for expansion

Cognivia bags €15.5M for expansion
Cognivia bags €15.5M for expansion

Cognivia, a Mont-Saint-Guibert, Belgium-based AI company focused on pharmaceutical and biotech research, has secured €15.5M in funding.

The round was led by Vesalius Biocapital IV, with participation from SFPIM and WE. The funds will be used to accelerate the deployment of Cognivia's predictive clinical trial solutions, which leverage AI and machine learning to decode the relationship between patient traits and behaviors.

CEO Dominique Demolle remarked, “This investment, coupled with the addition of new team members and advisors, positions us to enhance our innovative approaches, benefiting clinicians and patients worldwide.”

Cognivia integrates psychological data and AI to improve therapeutic efficacy measurements in clinical trials, aiming to expedite the development of new treatments globally. The company's unique technologies predict patient behavior and treatment responses using specially developed questionnaires and advanced ML algorithms.